Arslan, N. Et Al. 2000. Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis. ANNALS OF NUCLEAR MEDICINE , vol.14, no.5 , 395-399.

Arslan, N., Serdar, M., Deveci, S., Ozturk, B., Narin, Y., Ilgan, S., ... Ozturk, E.(2000). Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis. ANNALS OF NUCLEAR MEDICINE , vol.14, no.5, 395-399.

Arslan, N Et Al. "Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis," ANNALS OF NUCLEAR MEDICINE , vol.14, no.5, 395-399, 2000

Arslan, N Et Al. "Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis." ANNALS OF NUCLEAR MEDICINE , vol.14, no.5, pp.395-399, 2000

Arslan, N. Et Al. (2000) . "Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis." ANNALS OF NUCLEAR MEDICINE , vol.14, no.5, pp.395-399.

@article{article, author={N Arslan Et Al. }, title={Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis}, journal={ANNALS OF NUCLEAR MEDICINE}, year=2000, pages={395-399} }